Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-May 2010. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 59464701000001119 | Olanzapine 405mg powder and solvent for suspension for injection vials 1 vial (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 59464801000001111 | Olanzapine 405mg powder and solvent for suspension for injection vials 1 vial | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 59520501000001117 | Olanzapine pamoate 405mg powder and solvent for suspension for injection vials 1 vial | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 60831201000001114 | Olanzapine embonate 405mg powder and solvent for suspension for injection vials 1 vial | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Zypadhera 405mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) 1 vial | Is a | True | Olanzapine 405mg powder and solvent for suspension for injection vials 1 vial | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR